Literature DB >> 23281045

Stem cell attraction via SDF-1α expressing fat tissue grafts.

Stefan Zwingenberger1, Zhenyu Yao, Angela Jacobi, Corina Vater, Roberto D Valladares, Chenguang Li, Christophe Nich, Allison J Rao, Jane E Christman, Joseph K Antonios, Emmanuel Gibon, Axel Schambach, Tobias Mätzig, Klaus-Peter Günther, Stuart B Goodman, Maik Stiehler.   

Abstract

Mesenchymal stromal cell (MSCs) are key cellular components for site-specific tissue regeneration. The chemokine stromal derived factor 1 alpha (SDF-1α) is known to attract stem cells via the C-X-C chemokine receptor-4 (CXCR4) receptor. The aim of the study was to develop a model for stem cell attraction using SDF-1α overexpressing fat tissue grafts. Murine MSCs were lentiviral transduced to express the genes for enhanced green fluorescent protein, firefly luciferace, and human CXCR4 (hCXCR4). Murine fat tissue was adenoviral transduced to express SDF-1α and red fluorescent protein transgenes. MSCs were cultured on transwells with SDF-1α containing supernatants from transduced fat tissue. The numbers of migrated MSCs in four groups (with hCXCR4 positive (+) or hCXCR4 negative (-) MSCs with or without SDF-1α containing supernatant) were investigated. After 36 h of culture, 9025 ± 925 cells migrated through the membrane of the transwells in group 1 (CXCR4+/SDF-1α+), 4817 ± 940 cells in group 2 (CXCR4-/SDF-1α+), 2050 ± 766 cells in group 3 (CXCR4+/SDF-1α-), and 2108 ± 426 cells in group 4 (CXCR4-/SDF-1α-). Both, the presence of SDF-1α and the expression of hCXCR4 significantly increased the migration rates (p < 0.0001). MSCs overexpressing the CXCR4 receptor by lentiviral transduction are highly attracted by medium from SDF-1α expressing fat tissue in vitro. Thus, SDF-1α activated tissue grafts may be a strategy to enhance site-specific musculoskeletal tissue regeneration.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23281045      PMCID: PMC4056675          DOI: 10.1002/jbm.a.34512

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  37 in total

1.  Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone.

Authors:  D S Musgrave; P Bosch; S Ghivizzani; P D Robbins; C H Evans; J Huard
Journal:  Bone       Date:  1999-06       Impact factor: 4.398

2.  Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival.

Authors:  J J Lataillade; D Clay; C Dupuy; S Rigal; C Jasmin; P Bourin; M C Le Bousse-Kerdilès
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 3.  The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.

Authors:  M Z Ratajczak; E Zuba-Surma; M Kucia; R Reca; W Wojakowski; J Ratajczak
Journal:  Leukemia       Date:  2006-08-10       Impact factor: 11.528

4.  Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.

Authors:  Ahmed A Abdellatif; Jennifer L Pelt; Richard L Benton; Russell M Howard; Pantelis Tsoulfas; Peipei Ping; Xiao-Ming Xu; Scott R Whittemore
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

5.  Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1α in a sciatic nerve injury model.

Authors:  Dar-Yu Yang; Meei-Ling Sheu; Hong-Lin Su; Fu-Chou Cheng; Ying-Ju Chen; Chun-Jung Chen; Wen-Ta Chiu; Jia-Jean Yiin; Jason Sheehan; Hung-Chuan Pan
Journal:  J Neurosurg       Date:  2012-04-13       Impact factor: 5.115

Review 6.  Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.

Authors:  T Lapidot
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

7.  Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation.

Authors:  Quan Zhang; Qi-Fen He; Tong-Han Zhang; Xiao-Lin Yu; Qin Liu; Fei-long Deng
Journal:  Biomed Mater       Date:  2012-05-04       Impact factor: 3.715

8.  Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

Authors:  J Dawn Abbott; Yan Huang; Dingang Liu; Reed Hickey; Diane S Krause; Frank J Giordano
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

9.  Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model.

Authors:  Geoffroy Nourissat; Amadou Diop; Nathalie Maurel; Colette Salvat; Sylvie Dumont; Audrey Pigenet; Marjolaine Gosset; Xavier Houard; Francis Berenbaum
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

10.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

View more
  3 in total

1.  A Simple Method to Determine the Purity of Adipose-Derived Stem Cell-Based Cell Therapies.

Authors:  Denis Dufrane; Aurore Lafosse
Journal:  Stem Cells Transl Med       Date:  2016-07-08       Impact factor: 6.940

2.  Cell-based therapies for regenerating bone.

Authors:  S B Goodman
Journal:  Minerva Ortop Traumatol       Date:  2013-04-01

3.  Enhancement of BMP-2 induced bone regeneration by SDF-1α mediated stem cell recruitment.

Authors:  Stefan Zwingenberger; Zhenyu Yao; Angela Jacobi; Corina Vater; Roberto D Valladares; Chenguang Li; Christophe Nich; Allison J Rao; Jane E Christman; Joseph K Antonios; Emmanuel Gibon; Axel Schambach; Tobias Maetzig; Stuart B Goodman; Maik Stiehler
Journal:  Tissue Eng Part A       Date:  2013-11-12       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.